US.ZTS · Zoetis

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.373620457604307,
        "turnoverUsdM": 214.1441908,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.ZTS",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 70.7728,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 4.7,
      "take_profit_price": 79.6026,
      "target_multiplier": 2.2,
      "technical_strength": 2.05,
      "take_profit_percent": 7.1
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.4956055794964842,
    "stopLossPercent": 4.747240915208614,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 70.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 71.851,
    "ma50": 73.877,
    "close": 74.3,
    "prevClose": 75.65,
    "avgVolume20": 4369898,
    "volumeRatio": 0.66,
    "changePercent": -1.78
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.041637459694378265,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.650631859821481,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.9495649175024797,
      "volat_points": 0,
      "day_range_pct": 0.02288021534320327,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 70.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 86,
        "contribution": 4.3
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 20.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.33,
        "contribution": 20.8
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 61.1,
    "details": [
      "基本面分析總分: 4.3/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 20.8/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.3,
      "資金流": 12.4,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 20.8,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.5,
          "epsPoints": 0.4,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0.75,
          "turnoverUsdM": 214.1441908,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ZTS",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 741.33600115,
                "ma50": 726.5544004600001,
                "name": "QQQ",
                "close": 743.57001,
                "points": 2
              },
              "spy": {
                "ma20": 769.8689970499998,
                "ma50": 768.6025973799999,
                "name": "SPY",
                "close": 778.01001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.373620457604307,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142852685,
                "url": "https://finnhub.io/api/news?id=b4f73bc04760ed99ae425087ffdccb8743bd459bec8676a425e5ebcaa1a1ab25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at branded pharmaceuticals stocks, starting with Zoetis (NYSE:ZTS).",
                "category": "company",
                "datetime": 1791908344,
                "headline": "Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers"
              },
              {
                "id": 142805719,
                "url": "https://finnhub.io/api/news?id=d1ed17e76605d3bb1bc4f052951377f7b02e1277c0d41ff40c22be2f7dbd30ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis has seen its share price under pressure in recent years, even with a short-term bounce. This puts fresh attention on whether the current valuation is still supported by its earnings power. With the animal health group in the spotlight after mixed business updates, the key issue for you as an investor is what today's earnings actually justify. Over the past 5 years, Zoetis shareholders have seen the stock fall 60.9%, which makes the current price level a live question rather than a...",
                "category": "company",
                "datetime": 1791720702,
                "headline": "Zoetis (ZTS) Stock May Trade At A Discount As Q2 Pressure Persists"
              },
              {
                "id": 142768145,
                "url": "https://finnhub.io/api/news?id=65831ba99049f7d1895ce78c619d1859917817b1e920d945eff4668248b0f4fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from the previous trading day.",
                "category": "company",
                "datetime": 1791580505,
                "headline": "Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 142754007,
                "url": "https://finnhub.io/api/news?id=4baa07edb0173cb3c6df8828e8bb1501f402c4c9b2b857651a7bc282ce58221e",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis is a dividend stock with strong profitability, low payout ratio, and 20.56% dividend growth, but slower earnings remain a risk.",
                "category": "company",
                "datetime": 1791538836,
                "headline": "Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow"
              },
              {
                "id": 142732290,
                "url": "https://finnhub.io/api/news?id=22be5015ff8334f3bfeb497148b5c9b03f33028d27c8887e271efa1669d2fced",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) reported new peer-reviewed data on its Simparica Trio product comparing protection against resistant heartworm to NexGard Plus. The publication focuses on a resistant heartworm strain that has become a growing concern for veterinarians and dog owners. Researchers found Simparica Trio provided stronger protection against the resistant heartworm strain than competitor NexGard Plus in the study. Stronger protection by Simparica Trio against resistant heartworm only tells part...",
                "category": "company",
                "datetime": 1791482919,
                "headline": "Zoetis (ZTS) Says Study Shows Simparica Trio Outperformed A Rival On Resistant Heartworm"
              },
              {
                "id": 142571093,
                "url": "https://finnhub.io/api/news?id=37fe2ca1458d132e96a1ae9e443a3c633aa18af06559c6574ea35036977f4c99",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis Inc. (NYSE:ZTS) has built one of the strongest franchises in animal health. Its products are used by veterinarians around the world; its portfolio spans medicines, vaccines, and diagnostics, and its research capabilities have helped establish entire categories of treatment. But a moat is only valuable if it protects market share and pricing power when […]",
                "category": "company",
                "datetime": 1790909374,
                "headline": "Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?"
              },
              {
                "id": 142563955,
                "url": "https://finnhub.io/api/news?id=c980375e3b22071e3c11bec8d34ee762bf7e8770c79fed0b9bdd473835696a72",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change compared to its last close.",
                "category": "company",
                "datetime": 1790889305,
                "headline": "Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why"
              },
              {
                "id": 142411455,
                "url": "https://finnhub.io/api/news?id=8ba082f27b9286618155d08dddf3261ea716546bf563b9139ce5f5598492110a",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) screens as decent value: low P/E, strong 9/10 profitability, solid ROIC, and a sustainable dividend, though growth and leverage are risks.",
                "category": "company",
                "datetime": 1790328069,
                "headline": "Zoetis (NYSE:ZTS) Looks Like a Decent Value Stock"
              }
            ],
            "raw_source": [
              {
                "id": 142852685,
                "url": "https://finnhub.io/api/news?id=b4f73bc04760ed99ae425087ffdccb8743bd459bec8676a425e5ebcaa1a1ab25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at branded pharmaceuticals stocks, starting with Zoetis (NYSE:ZTS).",
                "category": "company",
                "datetime": 1791908344,
                "headline": "Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers"
              },
              {
                "id": 142847665,
                "url": "https://finnhub.io/api/news?id=22036da91f6405ab60c990d7250a0fdacf2ec6d0382b00144f92ac4554a519ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 13, 2026--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of December 1, 2026. With decades of experience across global media and consumer businesses, Ms. Knobloch brings a distinct combination of international leadership, proven public company board experience across financial services, hospitality and media, and deep consumer and digital expertise to the Zoetis Board. She currently serves on the boards of",
                "category": "company",
                "datetime": 1791891000,
                "headline": "Zoetis Appoints Iris Knobloch to its Board of Directors"
              },
              {
                "id": 142810765,
                "url": "https://finnhub.io/api/news?id=bd140ab014b5cf6f3e5ea4c4f50b6f6f01dd0f80f065768a70c0742a397f6f2a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688741730/image_688741730.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years. Check out dividend growth stocks here.",
                "category": "company",
                "datetime": 1791758522,
                "headline": "10 Dividend Growth Stocks: October 2026"
              },
              {
                "id": 142806662,
                "url": "https://finnhub.io/api/news?id=88a74baf83fffd8b419bb6c42be37ea4daa59b2aa69282ceb6e60f787cf3393b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2252678669/image_2252678669.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Track 50 top dividend growth stocks: AMAT, DHI & HD climb as valuations shift.",
                "category": "company",
                "datetime": 1791722816,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For October 2026"
              },
              {
                "id": 142805719,
                "url": "https://finnhub.io/api/news?id=d1ed17e76605d3bb1bc4f052951377f7b02e1277c0d41ff40c22be2f7dbd30ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis has seen its share price under pressure in recent years, even with a short-term bounce. This puts fresh attention on whether the current valuation is still supported by its earnings power. With the animal health group in the spotlight after mixed business updates, the key issue for you as an investor is what today's earnings actually justify. Over the past 5 years, Zoetis shareholders have seen the stock fall 60.9%, which makes the current price level a live question rather than a...",
                "category": "company",
                "datetime": 1791720702,
                "headline": "Zoetis (ZTS) Stock May Trade At A Discount As Q2 Pressure Persists"
              },
              {
                "id": 142768145,
                "url": "https://finnhub.io/api/news?id=65831ba99049f7d1895ce78c619d1859917817b1e920d945eff4668248b0f4fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from the previous trading day.",
                "category": "company",
                "datetime": 1791580505,
                "headline": "Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 142767072,
                "url": "https://finnhub.io/api/news?id=3d2ed8994bf06290bae931b73a6a13db796ca6fce85a100a435a5bc0dcd6e13f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Whether you want a higher 3% dividend yield or a quickly growing dividend that yields 1.2%, these two stocks look like rare opportunities.",
                "category": "company",
                "datetime": 1791576300,
                "headline": "A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now"
              },
              {
                "id": 142791211,
                "url": "https://finnhub.io/api/news?id=8515c8cafa622c1ba55b6a4727cf33da0134590c035e2163865fea16ff57ffd7",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1791552910,
                "headline": "10 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 142754007,
                "url": "https://finnhub.io/api/news?id=4baa07edb0173cb3c6df8828e8bb1501f402c4c9b2b857651a7bc282ce58221e",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis is a dividend stock with strong profitability, low payout ratio, and 20.56% dividend growth, but slower earnings remain a risk.",
                "category": "company",
                "datetime": 1791538836,
                "headline": "Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow"
              },
              {
                "id": 142733312,
                "url": "https://finnhub.io/api/news?id=85cbdaa0f9a83fa20249dead4b6503d31276c12c50796b88623a9c572c26e86b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 08, 2026--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on Tuesday, December 1, 2026, to all holders of record of the Company’s common stock as of the close of business on Friday, October 30, 2026.",
                "category": "company",
                "datetime": 1791490500,
                "headline": "Zoetis Declares Fourth Quarter 2026 Dividend"
              },
              {
                "id": 142732290,
                "url": "https://finnhub.io/api/news?id=22be5015ff8334f3bfeb497148b5c9b03f33028d27c8887e271efa1669d2fced",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) reported new peer-reviewed data on its Simparica Trio product comparing protection against resistant heartworm to NexGard Plus. The publication focuses on a resistant heartworm strain that has become a growing concern for veterinarians and dog owners. Researchers found Simparica Trio provided stronger protection against the resistant heartworm strain than competitor NexGard Plus in the study. Stronger protection by Simparica Trio against resistant heartworm only tells part...",
                "category": "company",
                "datetime": 1791482919,
                "headline": "Zoetis (ZTS) Says Study Shows Simparica Trio Outperformed A Rival On Resistant Heartworm"
              },
              {
                "id": 142731108,
                "url": "https://finnhub.io/api/news?id=664d09db37b68e5267609d3b907b91d63226bf384f6ab20679365506df8e3365",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.",
                "category": "company",
                "datetime": 1791476520,
                "headline": "Is it the Right Time to Add Phibro Stock to Your Portfolio?"
              },
              {
                "id": 142728425,
                "url": "https://finnhub.io/api/news?id=1f6b2e084f37767081588e49aa339e50321e0e63b9c9e2a1f99a82ceda8cdbbd",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2291417043/image_2291417043.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Neogen Corporation's products are used for detecting contamination, checking quality, and protecting livestock. Read more on NEOG stock here.",
                "category": "company",
                "datetime": 1791454968,
                "headline": "Neogen Corporation: Promising Recurring Demand With Food Safety"
              },
              {
                "id": 142698563,
                "url": "https://finnhub.io/api/news?id=c6e0ab0cf952b1b3147ea613e6a5b07cb02af2f0738298ab0bdc24fb3f8ef01a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "It's going to be a very long road back to all-time highs for some well-known companies.",
                "category": "company",
                "datetime": 1791389750,
                "headline": "These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks"
              },
              {
                "id": 142695147,
                "url": "https://finnhub.io/api/news?id=303b9019184f0fc4db851963052101f896b811e36a79ee7a385d3e7c2cfe2c44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Key TakeawaysNeogen shares jumped 4% after fiscal first-quarter revenue of $222. 8 million beat the $208.",
                "category": "company",
                "datetime": 1791380059,
                "headline": "Neogen Soars 4% as Q1 Revenue Beat and Raised Guidance Show “Encouraging Progress”"
              },
              {
                "id": 142662157,
                "url": "https://finnhub.io/api/news?id=16b38a3c85b62af7442841b64d8f56b21564d23cd5f5c671461a613f8e313ef9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 06, 2026--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today’s heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th",
                "category": "company",
                "datetime": 1791286200,
                "headline": "New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1"
              },
              {
                "id": 142662285,
                "url": "https://finnhub.io/api/news?id=7e1eb27d1f4ac3e3c7397391f053e54fcf4e19d49304b9e204a5b9fdef0c8732",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2256862219/image_2256862219.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "The 4-factor approach has averaged 18.76% total return, outperforming SCHD's 13.70% over completed 12-month cycles. Read more here.",
                "category": "company",
                "datetime": 1791274326,
                "headline": "SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For October 2026"
              },
              {
                "id": 142663812,
                "url": "https://finnhub.io/api/news?id=f1452b176c313c5241c1ec7c0a16c68a8296a70367f45b8d0a728d6276e2fd4c",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "On Thursday, Zoetis (NYSE:ZTS) discussed second-quarter financial results during its earnings call. The full transcript is provided below.\nThis transcript is brought to you by Benzinga APIs. For real-time access to our",
                "category": "company",
                "datetime": 1791269589,
                "headline": "Zoetis Reports Q2 2026 Results: Full Earnings Call Transcript"
              },
              {
                "id": 142571093,
                "url": "https://finnhub.io/api/news?id=37fe2ca1458d132e96a1ae9e443a3c633aa18af06559c6574ea35036977f4c99",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis Inc. (NYSE:ZTS) has built one of the strongest franchises in animal health. Its products are used by veterinarians around the world; its portfolio spans medicines, vaccines, and diagnostics, and its research capabilities have helped establish entire categories of treatment. But a moat is only valuable if it protects market share and pricing power when […]",
                "category": "company",
                "datetime": 1790909374,
                "headline": "Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?"
              },
              {
                "id": 142563955,
                "url": "https://finnhub.io/api/news?id=c980375e3b22071e3c11bec8d34ee762bf7e8770c79fed0b9bdd473835696a72",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change compared to its last close.",
                "category": "company",
                "datetime": 1790889305,
                "headline": "Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why"
              },
              {
                "id": 142559047,
                "url": "https://finnhub.io/api/news?id=37374ce9835e5c61e1fb08021bd85eeb42e992b8d15da14974361471f98b125b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "October 2026 Top 25 High-Growth Dividend Stocks trading 31% below intrinsic value, with a projected 22.53% annual return. Read full analysis here.",
                "category": "company",
                "datetime": 1790851234,
                "headline": "Top 25 High-Growth Dividend Stocks For October 2026"
              },
              {
                "id": 142558297,
                "url": "https://finnhub.io/api/news?id=a18bb0839f70d1043459f9e146edff1a12e0e68b0821cfd57c078e1f3dd2e383",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253044633/image_2253044633.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "The Top 25 stocks average a 3.38% dividend yield and appear ~31% undervalued by dividend yield theory. Read more on the list here.",
                "category": "company",
                "datetime": 1790848800,
                "headline": "Top 25 Attractive Dividend Stocks For October 2026"
              },
              {
                "id": 142512774,
                "url": "https://finnhub.io/api/news?id=a20db31969ad1df3967ae7ef539bdbdd5eb5f43bae7906b15b0adc5bc5eab093",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233435423/image_2233435423.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) stock: why shares fell 71% and what’s next. Margin strength, pipeline vs. 2030+ patent risks, and $113 fair value.",
                "category": "company",
                "datetime": 1790749881,
                "headline": "Zoetis: Priced For The Worst, Worth Buying"
              },
              {
                "id": 142411455,
                "url": "https://finnhub.io/api/news?id=8ba082f27b9286618155d08dddf3261ea716546bf563b9139ce5f5598492110a",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) screens as decent value: low P/E, strong 9/10 profitability, solid ROIC, and a sustainable dividend, though growth and leverage are risks.",
                "category": "company",
                "datetime": 1790328069,
                "headline": "Zoetis (NYSE:ZTS) Looks Like a Decent Value Stock"
              },
              {
                "id": 142387851,
                "url": "https://finnhub.io/api/news?id=ca26736c048f32c4a64f367eed802258cb34f9ccae06b457ed6297bec0a699e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the most recent trading session, Zoetis (ZTS) closed at $70.27, indicating a -1.87% shift from the previous trading day.",
                "category": "company",
                "datetime": 1790284505,
                "headline": "Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 142374762,
                "url": "https://finnhub.io/api/news?id=afd12c52cfc114dcd06c890a97a11e929c171a7e5ae694a372277e7636e07026",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., September 24, 2026--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, November 5, 2026. Chief Executive Officer Kristin Peck and Executive Vice President, Chief Financial Officer and Chief Operating Officer Jay Saccaro will review third quarter 2026 financial results and respond to questions from financial analysts.",
                "category": "company",
                "datetime": 1790249400,
                "headline": "Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results"
              },
              {
                "id": 142374718,
                "url": "https://finnhub.io/api/news?id=bc9b0f8635277ab701dcc3c163514dd4b9d9aa67b7a84b17824541920a541163",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "The companion animal diagnostics market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, registering an 8.7% CAGR. Growth is driven by rising pet healthcare spending, preventive care, chronic and infectious diseases, and advances in AI, molecular diagnostics, point-of-care testing and automated analyzers. Molecular diagnostics will record the fastest growth, while consumables remain the leading product segment. Asia Pacific is expected to be the fastest-growing reg",
                "category": "company",
                "datetime": 1790245140,
                "headline": "Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis"
              },
              {
                "id": 142319434,
                "url": "https://finnhub.io/api/news?id=ce1c8d1a96c9b68c393f9a4c963a38a8ddf7280e50e6e54292821d8119227e46",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Burry’s indirect AI bet is ERO, saying that data-center construction will intensify copper demand while new mines take 18 years to reach production.",
                "category": "company",
                "datetime": 1790044840,
                "headline": "'Big Short' Michael Burry Tunes Out AI ‘Woo-Hoos’ — Finds Opportunity In Copper, QXO And 3 More Stocks"
              },
              {
                "id": 142307435,
                "url": "https://finnhub.io/api/news?id=545c84699a3df7fd7048f41ca1f5431fed91499eecb251de8c0b988838ecb63e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.",
                "category": "company",
                "datetime": 1789981345,
                "headline": "1 Mid-Cap Stock with Exciting Potential and 2 We Turn Down"
              },
              {
                "id": 142263625,
                "url": "https://finnhub.io/api/news?id=1909df662a3d05fa752c4dcf8835cce4dc09d86754b98534a624e0c5ea8419b6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) closed at $71.4 in the latest trading session, marking a -2.22% move from the prior day.",
                "category": "company",
                "datetime": 1789769703,
                "headline": "Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note"
              },
              {
                "id": 142256377,
                "url": "https://finnhub.io/api/news?id=2f5ba0b69b89b7d3393a23e8f7a8f5e0fa7e217b6ff52d958ba596c7937c572d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2238013673/image_2238013673.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis is still generating the bigger part of its revenue in the United States, the picture for the overall market is different. Read why ZTS stock is a buy.",
                "category": "company",
                "datetime": 1789726477,
                "headline": "Zoetis: The Worst May Be Priced In"
              },
              {
                "id": 142252701,
                "url": "https://finnhub.io/api/news?id=8362b76d03b6ea6d4428be234fac0cc21eddbe3fe94a340816b11d368fd97d5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis is back in focus after analysts cut their fair value estimate from US$114.76 to US$96.00, a reduction of around 16% that resets expectations around what the stock might be worth. This shift lines up with more mixed analyst commentary, where many firms are trimming price targets and some are also dialing back their ratings as they reassess clinic trends, competition and pricing. Read on to see what is driving the updated narrative and how you can track the next moves in Zoetis. Stay...",
                "category": "company",
                "datetime": 1789719198,
                "headline": "Zoetis (ZTS) Stock Fair Value Falls After Mixed Analyst Cuts And Softer Growth Views"
              },
              {
                "id": 142239513,
                "url": "https://finnhub.io/api/news?id=f0a998a9fc2db0f6f8ae5c8cafef216d867e15074bbaf978510359c42ce3411d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and intensified competition in dermatology and parasiticides. Speaking at a Morgan Stanley conference, CEO Kri",
                "category": "company",
                "datetime": 1789707729,
                "headline": "Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales"
              },
              {
                "id": 142222016,
                "url": "https://finnhub.io/api/news?id=47d50d85c20479ed18c9e3fa585d3201d70a1e4a1314086448934057f669e065",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2237012189/image_2237012189.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) outlook: Q2 2026 revenue flat, U.S. companion animal sales -11%.",
                "category": "company",
                "datetime": 1789629655,
                "headline": "Zoetis: Companion Animal Weakness Keeps Me On The Sidelines"
              },
              {
                "id": 142218443,
                "url": "https://finnhub.io/api/news?id=98186856c3586c38022af322140aa9d4b4961c012b3ea2f3227af97da2201eca",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196087139/image_2196087139.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis faces near-term pressure from weaker US companion animal demand, increased competition, and margin compression. Learn more about ZTS stock now.",
                "category": "company",
                "datetime": 1789624362,
                "headline": "Zoetis: An Undervalued Compounder Hiding In Plain Sight"
              },
              {
                "id": 142216184,
                "url": "https://finnhub.io/api/news?id=e04efc9a21d71dab2a76e9bae9a049d7b39b35e9ddd4c5467047d0a414c97895",
                "image": "",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "",
                "category": "company",
                "datetime": 1789621023,
                "headline": "Zoetis: New Competition Changes The Story, But Not Yet The Rating"
              },
              {
                "id": 142140984,
                "url": "https://finnhub.io/api/news?id=61bfce5eb6aa623092c99762a118d45fe48ba1f5b77ac40d1d2aefdc62968a93",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis Inc. (ZTS) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 1:50 PM EDTCompany ParticipantsJames Saccaro - Executive VP,...",
                "category": "company",
                "datetime": 1789405297,
                "headline": "Zoetis Inc. (ZTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142134390,
                "url": "https://finnhub.io/api/news?id=fbb62dfa8e0fed487345641c7cfdeda79b4965325e62c70578837275a6b17764",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) passes a Best Dividend screen with a 7/10 dividend rating, strong profitability, low payout ratio, and a value tilt.",
                "category": "company",
                "datetime": 1789380657,
                "headline": "Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors"
              },
              {
                "id": 142128337,
                "url": "https://finnhub.io/api/news?id=5407a5844cc9dd3106cdde5d4ee746a431794cfe6f78e4b1c910f36d5c7c5a45",
                "image": "",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "",
                "category": "company",
                "datetime": 1789343679,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For September 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 39,
            "discarded_article_count": 26
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.8,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 4522920,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 4295580,
              "avg_vol_20": 4429780,
              "avg_vol_30": 4522920,
              "range_pct_10": 0.09313593539703906,
              "range_pct_20": 0.09313593539703906,
              "range_pct_30": 0.12422611036339172,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9497360112493699,
              "dist_to_20d_high": 0.018364381027876873,
              "down_shrink_days": 2,
              "breakout_level_20d": 75.69,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7497291440953411
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.373620457604307,
              "turnoverUsdM": 214.1441908,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.ZTS",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 70.7728,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.5,
            "stop_loss_percent": 4.7,
            "take_profit_price": 79.6026,
            "target_multiplier": 2.2,
            "technical_strength": 2.05,
            "take_profit_percent": 7.1
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.4956055794964842,
          "stopLossPercent": 4.747240915208614,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 1.7636,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.37
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 153.41
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0834
    },
    "kdj": {
      "d": 71.51,
      "j": 102.45,
      "k": 81.82,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 50.02
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 772244,
      "recentSlope": 1454584.4,
      "previousSlope": -1302610
    },
    "rsi": 60.43,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 70.4013,
      "position": "SAR喺價下",
      "distancePct": 5.25,
      "previousTrend": "上升"
    },
    "ma50": 73.877,
    "macd": {
      "macd": 0.003573021416826805,
      "trend": "強烈看漲",
      "signal": -0.6449508683391114,
      "histogram": 0.6485238897559382
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 71.7645,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 4
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.66,
      "score": 2,
      "avgVolume": 4369898,
      "currentVolume": 2882156
    },
    "derived": {
      "ma20": 71.851,
      "ma50": 73.877,
      "prevClose": 75.65,
      "avgVolume10": 4231706,
      "avgVolume20": 4369898,
      "changePercent": -1.78,
      "avgVolumeForScore": 4369898
    },
    "ma_cross": {
      "ma20": 71.851,
      "ma50": 73.877,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 71.8075,
      "prevMa50": 73.933,
      "spreadPct": 2.74,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 68.4588,
      "upper": 75.2432,
      "position": "上半部"
    },
    "rsi_short": 75.13,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.66
    }
  }
}

{
  "close": 74.3,
  "volume": 2882156,
  "changePercent": -1.78
}